Background: Hidradenitis suppurativa (HS), also known as acne inversa or Verneuil's
disease, is a chronic, inflammatory, recurrent, and debilitating skin disease of the hair …

Introduction Hidradenitis suppurativa (HS) is an autoinflammatory skin disease with a high
unmet need for effective medical management. Clinically, it is characterized by inflammatory …

The treatment of hidradenitis suppurativa (HS) has always been a real challenge for
dermatologists; to date, the only biologic drugs approved for HS are adalimumab, an anti …

Background Nail psoriasis (NP) has a prevalence that ranges from 10 to 82% among
patients with psoriasis (PsO) and is one of the most common difficult to treat site of psoriasis …

Background: Obesity and hidradenitis suppurativa (HS) are related through meta-
inflammation and are both associated with increased cardiometabolic risk. Notwithstanding …

Abstract Adalimumab (ADL, Humira®, reference product), an anti-TNF-α biologic, has
transformed the treatment of chronic, immune-mediated inflammatory diseases. However …

Introduction Generalized pustular psoriasis (GPP) is a rare form of psoriasis (less of 1% of
cases). Currently, GPP is recognized as a clinical entity, distinguished from plaque psoriasis …

Background: The COVID-19 pandemic period revolutionized daily clinical practice. Several
strategies were adopted by clinicians to avoid reducing treatment for diseases without the …

Background: Four vaccines have been authorized by the European Medicines Agency
(EMA): viral vector-based vaccines (AstraZeneca; AZD1222 and Johnson & Johnson; Ad26 …

Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated
with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa …